RubiconMD Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 105
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $128M
Latest Deal Amount

RubiconMD General Information

Description

Developer of a web-based e-consulting designed to connect primary care doctors with specialists. The company's platform allows primary care physicians to identify specialists based on ratings, cost and experience and receive opinions and recommendations based on data, enabling clients to make informed decisions related to patient care.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Parent Company
Primary Office
  • 330 Hudson Street
  • Suite 302
  • New York, NY 10013
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RubiconMD Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 21-Oct-2021 $128M 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 10-Mar-2020 0000 000.00 0000 Completed Generating Revenue
5. Later Stage VC (Series B) 19-Apr-2018 000.00 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jun-2016 000 00.000 0000 Completed Generating Revenue
3. Accelerator/Incubator 12-Jan-2015 00.000 Completed Startup
2. Early Stage VC (Series A) 10-May-2014 $1.5M $1.52M Completed Startup
1. Accelerator/Incubator 17-Jan-2014 $20K $20K Completed Startup
To view RubiconMD’s complete valuation and funding history, request access »

RubiconMD Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B1 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series B 7,197,674 $0.000100 8% $1.75 $1.75 1x $1.75 25.51%
Series A 4,490,676 $0.000100 8% $1.36 $1.36 1x $1.36 15.91%
To view RubiconMD’s complete cap table history, request access »

RubiconMD Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a web-based e-consulting designed to connect primary care doctors with specialists. The company's platform
Other Healthcare Technology Systems
New York, NY
105 As of 2021
000.00
0000 0000-00-00
000000&0 000.00

00000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000000000 0000000 (0000000000)
Boston, MA
00 As of 0000
0000
000000&0 0000

00000 00

e cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cu
00000 0000000000 0000000000 0000000
Marietta, GA
000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RubiconMD Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Par8o Formerly VC-backed Boston, MA 00 0000 000000&0 0000
00000 000000 Private Equity-Backed Marietta, GA 000 000000000000
000000 000000 Private Equity-Backed Atlanta, GA 000 000.00 000000000 000.00
00000 Venture Capital-Backed Corte Madera, CA 00 000.00 00000000000 000.00
000000000 Corporation Somerset, NJ 0000 000.00 00000000000 000.00
You’re viewing 5 of 18 competitors. Get the full list »

RubiconMD Patents

RubiconMD Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-7699865-B2 Actuating constraining mechanism Active 12-Sep-2003 000000000 000
US-20050085848-A1 Actuating constraining mechanism Granted 12-Sep-2003 000000000 00
US-20050096692-A1 Methods, systems, and devices for providing embolic protection and removing embolic material Granted 12-Sep-2003 0000000000 000
CA-2538336-A1 Methods, systems, and devices for providing embolic protection and removing embolic material Abandoned 12-Sep-2003 0000000000
US-8535344-B2 Methods, systems, and devices for providing embolic protection and removing embolic material Active 12-Sep-2003 A61F2/0105 0
To view RubiconMD’s complete patent history, request access »

RubiconMD Executive Team (16)

Name Title Board Seat Contact Info
Gilbert Addo Jr. Co-Founder, Chief Executive Officer & Board Member
Fred Ronnau Chief Technology Officer
Troy Jelinek Chief Client Officer
Carlos Reines Co-Founder, President & Board Member
Cyprian Kibuka Vice President, Business Development
You’re viewing 5 of 16 executive team members. Get the full list »

RubiconMD Board Members (13)

Name Representing Role Since
Andrew Bouldin Self Board Member 000 0000
Carlos Reines RubiconMD Co-Founder, President & Board Member 000 0000
Enrico Picozza HLM Venture Partners Board Member 000 0000
Gilbert Addo Jr. RubiconMD Co-Founder, Chief Executive Officer & Board Member 000 0000
James Lesko Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

RubiconMD Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RubiconMD Former Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alumni Ventures Venture Capital Minority 000 0000 000000 0
Athenahealth PE-Backed Company Minority 000 0000 000000 0
Blueprint Health Accelerator/Incubator Minority 000 0000 000000 0
California Health Care Foundation Other Minority 000 0000 000000 0
Catapult VC Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »